Roth Capital Reiterates Buy on IperionX, Raises Price Target to $74
Benzinga Newsdesk 1 year ago
NewsPrice TargetReiterationAnalyst Ratings
Roth Capital analyst Joe Reagor reiterates IperionX (NASDAQ:IPX) with a Buy and raises the price target from $64 to $74.
Roth Capital analyst Joe Reagor reiterates IperionX (NASDAQ:IPX) with a Buy and raises the price target from $64 to $74.